JFL Life Sciences Ltd (JFLLIFE) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by JFL Life Sciences Ltd on NSE and BSE, with an AI summary of each filing.
Jfl Life Sciences Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015'.
Others (Uncategorized) · 04 Nov 2026, 12:27 am
Gujarat GST Authorities Initiate Search Proceedings at JFL Life Sciences Units Gujarat State GST officials initiated search and inspection proceedings at select registered offices and manufacturing units of JFL Life Sciences on 3rd Nov'26 under Section 67 of the Gujarat Goods and Services Tax Act, 2017. The inspection is underway, with the company extending full cooperation. No communication regarding specific alleged violations has been received yet. The company stated that the ongoing proceedings currently have no material financial or operational impact on its business activities.
Jfl Life Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 02 Nov 2026, 9:36 pm
JFL Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 9,865 (+229.8% YoY | +788.5% QoQ) ■ EBITDA: 665 (+128.0% YoY | +217.5% QoQ) ■ EBITDA Margin (%): 6.7 (-301 bps YoY | -1212 bps QoQ) ■ PAT: 423 (+114.1% YoY | +279.6% QoQ) ■ EPS (INR): 1.28 (+113.3% YoY | +276.5% QoQ)
JFL LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 02 Nov 2026, 5:30 am
JFL Life Sciences Schedules Board Meeting on 2nd Nov'26 for Q2 Financial Results JFL Life Sciences Limited has scheduled a meeting of its Board of Directors on 2nd Nov'26. The board will inter-alia consider, approve, and take on record the unaudited financial results of the company for the quarter ended Sep'26.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 02 Nov 2026, 5:30 am
JFL Life Sciences Schedules Board Meeting for Q2 and H1 Financial Results JFL Life Sciences Limited has scheduled its Board of Directors meeting for 2nd Nov'26 at its registered office. The board will primarily consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26, alongside taking on record the Limited Review Report from statutory auditors.
Jfl Life Sciences Limited has informed the Exchange regarding Appointment of Mrs BHAVNA SHAH ID Reappointment as Independent Director of the company w.e.f. February 10, 2027.
Change in Management · 27 Aug 2026, 4:42 am
JFL Life Sciences Confirms Key Management Re-appointments JFL Life Sciences has re-appointed key management personnel for five-year terms. Mr. Smiral Ashwinkumar Patel is re-appointed as Managing Director, effective from 18th Jan'27 to 17th Jan'32. Mrs. Tejal Smiral Patel is re-appointed as Whole-time Director for the same term. Additionally, Ms. Sonu Lalitkumar Jain and Ms. Bhavna Basantbhai Shah have been re-appointed as Non-Executive Independent Directors for their second five-year terms, commencing 18th Jan'27 and 10th Feb'27, respectively, ensuring leadership continuity.
Jfl Life Sciences Limited has informed the Exchange regarding Appointment of Mr SONU JAIN Reappointment ID as Independent Director of the company w.e.f. January 18, 2027.
Change in Management · 27 Aug 2026, 4:39 am
JFL Life Sciences Announces Key Leadership Re-appointments JFL Life Sciences (NSE: JFLLIFE) has re-appointed key board members at its 16th AGM. Mr. Smiral Ashwinkumar Patel continues as Managing Director for a five-year term from 18th Jan'27 to 17th Jan'32. Mrs. Tejal Smiral Patel was re-appointed as Whole-time Director for the same five-year period. Additionally, Ms. Sonu Lalitkumar Jain was re-appointed as a Non-Executive Independent Director, also for a term from 18th Jan'27 to 17th Jan'32, while Ms. Bhavna Basantbhai Shah was re-appointed for a second term from 10th Feb'27 to 09th Feb'32.
Jfl Life Sciences Limited has informed the Exchange regarding Appointment of Mrs Tejal Smiral Patel WTD Reappointment as Executive Director of the company w.e.f. January 18, 2027.
Change in Management · 27 Aug 2026, 4:36 am
JFL Life Sciences Announces Key Management Re-appointments for Five-Year Terms JFL Life Sciences has re-appointed key executives for five-year terms. Smiral Ashwinkumar Patel continues as Managing Director and Tejal Smiral Patel as Whole-time Director, with both terms effective from 18th Jan'27 to 17th Jan'32. Sonu Lalitkumar Jain has also been re-appointed as a Non-Executive Independent Director for the same period. Additionally, Bhavna Basantbhai Shah was re-appointed as a Non-Executive Independent Director for a five-year term commencing 10th Feb'27 and ending 9th Feb'32. All appointments were approved at the 16th AGM.
Jfl Life Sciences Limited has informed the Exchange regarding Appointment of Mr Mr. Smiral Ashwinkumar Patel (Re-Appointment ) as Managing Director of the company w.e.f. January 18, 2027.
Change in Management · 27 Aug 2026, 4:28 am
JFL Life Sciences Announces Multiple Key Director Re-appointments JFL Life Sciences has re-appointed key board members for five-year terms. Mr. Smiral Ashwinkumar Patel is re-appointed as Managing Director and Mrs. Tejal Smiral Patel as Whole-time Director, both effective from 18th Jan'27 to 17th Jan'32. Additionally, Ms. Sonu Lalitkumar Jain and Ms. Bhavna Basantbhai Shah were re-appointed as Non-Executive Independent Directors. Ms. Jain's term runs from 18th Jan'27 to 17th Jan'32, while Ms. Shah's term is from 10th Feb'27 to 09th Feb'32, ensuring leadership continuity.
Jfl Life Sciences Limited has informed the Exchange about General Updates
Others (Uncategorized) · 27 Aug 2026, 4:21 am
JFL Life Sciences Confirms Key Leadership Re-Appointments JFL Life Sciences (JFLLIFE) has re-appointed key board members for five-year terms. Mr. Smiral Ashwinkumar Patel continues as Managing Director, and Mrs. Tejal Smiral Patel as Whole-Time Director, with both terms running from 18th Jan'27 to 17th Jan'32. Ms. Sonu Lalitkumar Jain has also been re-appointed as a Non-Executive Independent Director for the same period. Additionally, Ms. Bhavna Basantbhai Shah was re-appointed as a Non-Executive Independent Director for a term from 10th Feb'27 to 9th Feb'32, ensuring leadership continuity.
Jfl Life Sciences Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 25, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 27 Aug 2026, 4:07 am
Jfl Life Sciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 25, 2026
Annual General Meeting · 25 Aug 2026, 11:23 pm
Jfl Life Sciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Outcome · 10 Aug 2026, 11:09 pm
JFL Life Sciences Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakhs) ■ Revenue: 1,110 (-4.2% YoY | -82.4% QoQ) ■ EBITDA: 209 (+8.2% YoY | -40.5% QoQ) ■ EBITDA Margin (%): 18.9 (+216 bps YoY | +1328 bps QoQ) ■ PAT: 111 (+49.3% YoY | -32.9% QoQ) ■ EPS (INR): 0.34 (+47.8% YoY | -32.0% QoQ)
JFL LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 10-Aug-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2026 .
Intimation · 10 Aug 2026, 5:30 am
JFL Life Sciences Board Meeting to Approve Q1FY27 Financial Results JFL Life Sciences will hold a Board Meeting on 10-Aug-'26 to consider and approve the company's unaudited financial results for the quarter ending Jun-'26.
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
Intimation · 29 Jun 2026, 5:30 am
JFL Life Sciences Board Meeting on Aug 10, '26 to Approve Q1 Results JFL Life Sciences has scheduled a Board of Directors meeting on Mon, Aug 10, '26. The primary agenda is to consider and approve the unaudited financial results for the quarter ended Jun 30, '26. The board will also review the Limited Review Report and discuss any other relevant business matters.
Newspaper Publication of Notice for Shareholder s Meeting 25th august,2026
Annual General Meeting · 01 Aug 2026, 7:16 pm
Jfl Life Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 25, 2026
Annual General Meeting · 31 Jul 2026, 10:04 pm